Portal de Periódicos da CAPES

Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal

2024; Ordem dos Médicos; Volume: 37; Issue: 5 Linguagem: Inglês

10.20344/amp.19178

1646-0758

José Vera, André Gomes, Diana Póvoas, Diana Seixas, Fernando Maltêz, Isabel Pedroto, Luís Maia, Margarida Mota, Maria João Vieira, Maria José Manata, Paula Ferreira, Sara Lino, Tiago Pereira Guedes, V Barradas, Nuno Marques,

Liver Disease Diagnosis and Treatment

Information about pan-genotypic treatments for hepatitis in Portugal is scarce. We aimed to evaluate the effectiveness and safety of glecaprevir plus pibrentasvir (GLE/PIB) treatment for hepatitis C virus (HCV) infection in real-world clinical practice.